Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer
Abstract Background Bladder cancer has numerous genomic features that are potentially actionable by targeted agents. Nevertheless, both pre-clinical and clinical research using molecular targeted agents have been very limited in bladder cancer. Results We created the Genomics of Drug Sensitivity in...
Main Authors: | Adnan Ahmad Ansari, Inkeun Park, Inki Kim, Sojung Park, Sung-Min Ahn, Jae-lyun Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12920-018-0406-2 |
Similar Items
-
IPCT: Integrated Pharmacogenomic Platform of Human Cancer Cell Lines and Tissues
by: Muhammad Shoaib, et al.
Published: (2019-02-01) -
Clinical application of drug sensitive gene detection in postoperative instillation for non-muscle invasive bladder cancer
by: Zhenlong Wang, et al.
Published: (2020-10-01) -
Biomarkers in Bladder Cancer: Present Status and Perspectives
by: Wun-Jae Kim, et al.
Published: (2007-01-01) -
Personalized medicine in breast cancer: pharmacogenomics approaches
by: Jeibouei S, et al.
Published: (2019-05-01) -
Pharmacogenomics, Pharmacokinetics and Circulating Proteins as Biomarkers for Bevacizumab Treatment Optimization in Patients with Cancer: A Review
by: Apostolos Papachristos, et al.
Published: (2020-08-01)